The company
Insight Molecular Diagnostics Inc.
IMDX · Nasdaq
IMDX stood above a rising 150-day average in 24 of the last 52 weekly readings, and has been out of that trend for the last 18 weeks. It is 35.7% below that average now. Diagnostics & Labs: 50% of its 44 stocks in an uptrend (+2 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 18
- Industry in uptrend
- 50% +2 in 4 wk
- Insider buys, 12 months
- $11.4M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 40 (+2)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 24 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Broadwood Partners, L.p.10% owner | bought | 250,923at $3.64 | 27 Apr 2026filed 27 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 0at $0.00 | 27 Apr 2026filed 27 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 38,880at $3.53 | 24 Apr 2026filed 27 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 0at $0.00 | 24 Apr 2026filed 27 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 280,381at $3.50 | 23 Apr 2026filed 27 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 0at $0.00 | 23 Apr 2026filed 27 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 40,690at $3.88 | 20 Apr 2026filed 20 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 0at $0.00 | 20 Apr 2026filed 20 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 40,114at $3.57 | 17 Apr 2026filed 20 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 0at $0.00 | 17 Apr 2026filed 20 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 102,057at $3.45 | 16 Apr 2026filed 20 Apr 2026 |
| Broadwood Partners, L.p.10% owner | bought | 0at $0.00 | 16 Apr 2026filed 20 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BROADWOOD CAPITAL INCadded · filed 14 Aug 2026 | 12,684,884$74.8M | +753,045+6.3% |
| AWM Investment Company, Inc.added · filed 14 Aug 2026 | 2,836,692$16.7M | +30,436+1.1% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 735,847$4.3M | +198,686+37.0% |
| PURA VIDA INVESTMENTS, LLCreduced · filed 13 Aug 2026 | 484,845$2.9M | -462,289−48.8% |
| Family Office Research LLCadded · filed 27 Jul 2026 | 368,849$2.2M | +241,583+189.8% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 256,903$1.5M | -5,150−2.0% |
| JANE STREET GROUP, LLCnew · filed 14 Aug 2026 | 157,682$930K | +157,682 |
| BlackRock, Inc.added · filed 7 Aug 2026 | 150,521$888K | +15,176+11.2% |
| VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 2026 | 124,576$735K | -8,015−6.0% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 92,124$544K | +41,370+81.5% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.